At a glance
- Originator Abbott Laboratories
- Class Antifungals
- Mechanism of Action Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
- 29 Apr 1999 No-Development-Reported for Mycoses in USA (Unknown route)
- 21 Aug 1997 New profile